ICD-10-CM · CMS Reimbursement Intelligence

C78.00Secondary malignant neoplasm of unspecified lung

Category: C78 · Secondary malignant neoplasm of unspecified lung ·  Verified:

ICD-10-CM FY2026

Active alerts

3

CMS Coverage Database

Critical / High

Priority signals

Recoverable revenue

$13,571

Conservative annual est.

Sources monitored

7 MAC contractors

Full coverage + CMS

Code definition & billing validity

ICD-10-CM Code

C78.00

Code System

ICD-10-CM FY2026

CDC + CMS adopted

Billing status

Billable diagnosis code

Valid for Medicare claim submission

Full clinical description

Secondary malignant neoplasm of unspecified lung

Coverage check · verified

Which Medicare LCDs cover C78.00, by MAC?

The LCDs whose CMS Billing & Coding article lists C78.00as covered or non-covered — each jurisdiction, effective-dated, linked to the government document. No guesses; if a policy isn’t on file we say so.

See the per-MAC coverage crosswalk for C78.00 — free.

Create a free account to unlock which LCDs — and which MAC jurisdictions — list this diagnosis as covered or non-covered, their effective dates, and the latest CMS revision — all source-linked. No card required.

MAC coverage considerations

Local Coverage Determinations (LCDs) from Medicare Administrative Contractors may impose medical necessity requirements for services billed with C78.00. Coverage criteria vary by MAC jurisdiction. Every contractor publishes its LCDs to the CMS Medicare Coverage Database, and CLV Intelligence tracks that database daily for LCD updates affecting this code and related codes.

Active CMS & MAC policy alerts

3 policy changes matched to C78.00

Matched by CLV analysis of each policy; the linked source document is authoritative.

Active monitoring

LCD L39230: MolDX: Plasma-Based Genomic Profiling in Solid Tumors — Noridian

LCD-L39230Oncology · Jun 5, 2026

Government source· CMS / MACverify ↗
Routine

Full analysis and action recommendations available with a CLV subscription.

Estimated recoverable revenue at risk

$13,571

Conservative annual estimate · 4% error rate · 60% capture

2 additional alerts locked

  • Full alert text + action recommendations
  • Direct MAC LCD and CMS source links
  • Effective date calendar and 30-day deadline tracking
  • Signal score rationale and audit risk rating

No credit card requiredCancel anytimeUpdated daily

MAC jurisdiction coverage

All seven Medicare Administrative Contractors (MACs) are monitored daily for LCD revisions, billing guidance, and coverage policy updates affecting ICD-10-CM C78.00.

Noridian

JE · JF

Alaska, Arizona, California, Hawaii, Idaho, Montana, Nevada, North Dakota, Oregon, South Dakota, Utah, Washington, Wyoming

CGS

J15

Kentucky, Ohio

Palmetto GBA

JJ · JM

North Carolina, South Carolina, Virginia, West Virginia + Georgia, Tennessee

NGS

J6 · JK

Illinois, Minnesota, Wisconsin + Connecticut, Maine, Massachusetts, New Hampshire, New York, Rhode Island, Vermont

WPS

J5 · J8

Iowa, Kansas, Missouri, Nebraska + Indiana, Michigan

First Coast

JN

Florida, Puerto Rico, U.S. Virgin Islands

Novitas

JH · JL

Arkansas, Colorado, Louisiana, Mississippi, New Mexico, Oklahoma, Texas + Delaware, D.C., Maryland, New Jersey, Pennsylvania

Search C78.00 across the full alert archive

Every CMS transmittal, MAC LCD, and Federal Register notice matched to this code.

Search all alerts

Audit documentation

Building an audit file that includes ICD-10 C78.00?

The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Oncology audit pack — $349One-time purchase · not a subscription

Frequently asked

What are the active CMS reimbursement alerts for ICD-10-CM code C78.00?
According to CLV Intelligence data, 3 active CMS and MAC reimbursement policy changes are matched to ICD-10-CM code C78.00 (Secondary malignant neoplasm of unspecified lung) by CLV analysis of each policy. Policies are sourced from CMS transmittals, Medicare Administrative Contractor (MAC) Local Coverage Determinations (LCDs), and Federal Register notices; the linked source document is authoritative. Data is updated daily.
Which MAC contractors publish LCD or billing guidance for C78.00?
According to CLV Intelligence data, Local Coverage Determinations (LCDs) and billing guidance relevant to ICD-10-CM code C78.00 (Secondary malignant neoplasm of unspecified lung) may be issued by any of the seven Medicare Administrative Contractors (MACs): Noridian Healthcare Solutions (Jurisdictions E and F), CGS Administrators (Jurisdiction 15), Palmetto GBA (Jurisdictions J and M), NGS (Jurisdictions 6 and K), WPS Government Health Administrators (Jurisdictions 5 and 8), First Coast Service Options (Jurisdiction N), and Novitas Solutions (Jurisdictions H and L). CLV Intelligence monitors all MAC jurisdictions daily and surfaces alerts by jurisdiction so clinical coders can filter to their region.
Is ICD-10-CM code C78.00 billable under Medicare in 2025–2026?
ICD-10-CM code C78.00 — Secondary malignant neoplasm of unspecified lung — is a valid billable diagnosis code under the ICD-10-CM FY2026 code set maintained by the Centers for Disease Control and Prevention (CDC) and adopted by CMS for Medicare and Medicaid billing. CLV Intelligence tracks CMS fee schedule updates, LCD revisions, and coverage policy changes that may affect reimbursement eligibility for this code. Coders should verify against the most recent MAC LCD and CMS NCCI edits before submission.

Get notified when CMS or MAC policy changes affect C78.00

Free weekly digest — no credit card required.

Get the free 90-day policy snapshot for your specialty

Free — no account required

See what CLV monitors for your specialty

Get a free 90-day sample snapshot — a PDF of every CMS and MAC policy change we tracked for your specialty and jurisdiction in the last quarter. Delivered instantly.

90-day windowPDF sample reportInstant download

By downloading, you agree to receive related policy update emails. You can unsubscribe at any time. Privacy policy